Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

What Role do Biobanks Play in Cancer Research?

Cancer Classification

Why are Cancer Cell Lines Useful?

Cancer Prognosis

The Biochemistry of Breast Cancer Screening

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

Pediatric Cancer

Investigating the Molecular Mechanisms of Cancer

What is Immunochemotherapy?

What is Cancer?

Caring for a Loved One with Cancer

See more featured articles »

Cancer Management

Is Cancer a Metabolic Disorder?

What is Merkel Cell Carcinoma?

CDK9 and Cancer

Cancer Pain Management

Effects of Social and Economic Deprivation on Cancer Mortality

What Causes Cancer?

Myc Mutations and Cancer

Cancer Pathophysiology

Cancer Symptoms

The Cancer Cell Surface Proteome as a Therapeutic Target

Insights into Oncofertility

What is the Tumor Microenvironment?

Metastatic Migration in Cancer may be Influenced by Metabolism

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

Acidosis and Tumor Progression

Cancer Pain

Cancer History

Cancer Research

Cancer Prevention: Lowering your Risk

Microfluidic cancer treatment screen combined with flow cytometry

Cancer Epidemiology

What is Cancer of Unknown Primary?

TARDIS: The Improved Method of Detecting Breast Cancer

Cancer Diagnosis

Using Biomarkers to Detect Cancer

The Effects of Cancer on Family Life

Targeted Cancer Therapies

Assay for Monitoring and Treating Malignant Brain Tumors

Insight into Cancer Vaccines

Hypoxia Markers and Their Importance

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cutaneous Manifestations of Internal Malignancy

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Cancer Screening Considerations: Balancing the Benefits and Risks

Hot vs Cold: the differences between tumor types

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Extracellular Vesicles as Floating Cancer Biomarkers

Transforming Cancer Care through Genomic Testing

What is Tumorigenesis?

Cancer Glossary

Secondary Brain Cancer

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

Living with Cancer Pain

Overview of Cell Viability and Cytotoxicity

Secondary Lung Cancer

British Pioneers in Cancer Biology

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

Latest Cancer News and Research

Scientists reveal why common pancreatic precancer lesions rarely turn deadly

Spatial and single-cell analyses of human donor pancreata showed that PanIN epithelial cells gradually acquire cancer-like molecular features, while their surrounding stromal and immune environment remains closer to normal pancreatic tissue. The findings suggest that delayed or incomplete microenvironmental reprogramming may help explain why most PanIN lesions remain indolent rather than progressing to pancreatic cancer.

24 May 2026

New advances improve prevention and treatment of HPV-related cancers

A new review article is drawing attention to the growing global impact of human papillomavirus (HPV) and the rapid progress in vaccines and therapeutic strategies aimed at reducing the burden of cervical and non-cervical cancers.

24 May 2026

RNA regulator RBM15 linked to immunity, metabolism, and cancer progression

A newly published review article brings attention to the expanding role of RBM15, a critical regulator of RNA m6A methylation, in the development and progression of a wide range of diseases, including cancer, metabolic disorders, and cardiovascular conditions.

24 May 2026

Efferocytosis plays central role in wound healing and tissue repair

A new review shines a spotlight on efferocytosis, a critical biological process responsible for the removal of dead cells, as a central force in promoting efficient wound repair and maintaining tissue balance.

24 May 2026

DNA methylation variability may improve precision cancer treatment strategies

A new review article brings attention to the critical role of DNA methylation heterogeneity in shaping the tumor microenvironment, highlighting its growing importance in understanding cancer progression and advancing more precise treatment strategies.

24 May 2026

Researchers uncover immune mechanisms behind polycystic kidney disease progression

A new review has illuminated a critical but often overlooked dimension of autosomal dominant polycystic kidney disease (ADPKD)—its immune microenvironment.

24 May 2026

DNA repair gene variations reveal evolutionary roots of cancer susceptibility

A new review highlights how human evolution has shaped the presence of pathogenic variations in DNA damage repair (DDR) genes, offering a new perspective on why modern populations face increased cancer susceptibility.

24 May 2026

Extrachromosomal circular DNA shows promise for precision disease diagnostics

A new scientific focus on extrachromosomal circular DNA (eccDNA) is opening transformative possibilities for disease detection, monitoring, and personalized medicine.

24 May 2026

Long non-coding RNAs regulate natural killer cell immune responses

A new review article highlights the powerful influence of long non-coding RNAs (lncRNAs) in regulating natural killer (NK) cells, revealing promising opportunities to enhance immune responses and improve treatment strategies across multiple diseases.

24 May 2026

Immunoproteasome plays emerging role in diabetes and metabolic complications

A newly published review article highlights the emerging importance of the immunoproteasome in the development and progression of diabetes and its wide-ranging complications, offering fresh perspectives on future therapeutic strategies.

24 May 2026

RNA modifications shape gut immunity and intestinal macrophage function

A new perspective on gut immunity is highlighting the powerful role of RNA modifications in shaping how the body maintains balance in the digestive system.

24 May 2026

RNA regulator YTHDF2 plays key role in controlling inflammation

A new review highlights the emerging importance of YTHDF2, a key regulator of RNA activity, in shaping the body's inflammatory responses and influencing a wide range of diseases.

24 May 2026

Early lung damage patterns uncovered in children with cystic fibrosis

Researchers have mapped how lung damage begins early in life for children with cystic fibrosis, providing new insights that will help reshape future care.

24 May 2026

Scientists visualize a key cell protein regulating inflammatory disease pathways

University of Cincinnati structural biologists are the first in the world to visualize a key cell protein as part of newly published research from the College of Medicine.

22 May 2026

AI-engineered p53 superproteins may reshape future cancer therapies

The Oncodarwinian Hypothesis (OdH) proposes a paradigm shift: cancer is not merely a disease but a potential macro‑immunoadaptive response – a self‑replicating algorithm that can be reprogrammed via AI‑based 3D printed p53 superproteins.

22 May 2026

Bioinformatics accelerates discovery of marine-derived bioactive therapeutic peptides

Marine organisms have evolved a remarkable arsenal of host-defense peptides under conditions of extreme variability and constant pathogen exposure. Generally defined as short chains of 2 to 20 amino acid residues, these molecules have become a focal point for biomedicine, food science, and materials science.

22 May 2026

Internal mutations and microbes may drive a distinct subtype of oral cancer

A new study reveals that many oral cancers are no longer driven by traditional risk factors like smoking or Human papillomavirus infection.

22 May 2026

Mitochondrial checkpoint enables dendritic cells to activate T lymphocytes against viruses, tumors

A study led by researchers at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) has identified a mitochondrial "checkpoint" that enables dendritic cells to efficiently activate T lymphocytes against viruses and tumors.

22 May 2026

New biomarker predicts therapy response for hard-to-treat childhood cancers

A study by researchers at the University of Birmingham has identified a new biomarker for response to a specific cancer therapy, treating children with Ewing Sarcoma and other tumor types.

22 May 2026

Scientists map genetic variants behind prostate cancer therapy failure

Recently, the research group led by Dr. Dechao Feng, Lecturer at University College London (UCL) and Distinguished Research Fellow at Zhejiang Provincial People's Hospital, published a review entitled "Intratumoral Androgens and Genetic Variants Driving Therapy Resistance in Prostate Cancer".

22 May 2026